The role of botulinum toxin type B (Myobloc) in the treatment of hyperkinetic facial lines: Discussion

Rod J. Rohrich, Jeffrey E. Janis

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)94S-95S
JournalPlastic and reconstructive surgery
Volume112
Issue number5 SUPPL.
DOIs
StatePublished - Oct 1 2003

ASJC Scopus subject areas

  • Surgery

Cite this